BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 32400761)

  • 1. A rare presentation of primary synchronous renal tract tumours on (18F)- fluorodeoxyglucose positron emission tomography- computed tomography.
    Ahmad W; Gill SM; Hassan A
    J Pak Med Assoc; 2020 May; 70(5):942-943. PubMed ID: 32400761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PET/Computed Tomography in Renal, Bladder, and Testicular Cancer.
    Bouchelouche K; Choyke PL
    PET Clin; 2015 Jul; 10(3):361-74. PubMed ID: 26099672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of renal cell carcinoma histological subtype and fuhrman grade using
    Nakajima R; Nozaki S; Kondo T; Nagashima Y; Abe K; Sakai S
    Eur Radiol; 2017 Nov; 27(11):4866-4873. PubMed ID: 28523353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Utility of early dynamic and delayed post-diuretic
    Sharma A; Mete UK; Sood A; Kakkar N; Gorla AK; Mittal BR
    Br J Radiol; 2017 Apr; 90(1072):20160787. PubMed ID: 28256904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Positron emission tomography for prostate, bladder, and renal cancer.
    Schöder H; Larson SM
    Semin Nucl Med; 2004 Oct; 34(4):274-92. PubMed ID: 15493005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FDG in Urologic Malignancies.
    Høilund-Carlsen PF; Poulsen MH; Petersen H; Hess S; Lund L
    PET Clin; 2014 Oct; 9(4):457-68, vi. PubMed ID: 26050947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Usefulness of PET/CT 18-FDG for the diagnosis and follow-up of urological, urothelial and kidney tumours.
    González-Ruiz de León C; García-Rodríguez J; Pérez-Castro N; Vigil-Díaz C; Pérez-Haro ML; Fernández-Gómez JM
    Actas Urol Esp (Engl Ed); 2019; 43(1):32-38. PubMed ID: 30100141
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Al-Zubaidi M; Viswambaram P; McCombie S; Liow E; Lenzo N; Ferguson T; Redfern AD; Gauci R; Hayne D
    BMJ Open; 2022 Apr; 12(4):e060478. PubMed ID: 35428649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bilateral primary renal lymphoma in a pediatric patient: staging and response evaluation with ¹⁸F-FDG PET/CT.
    Dhull VS; Mukherjee A; Karunanithi S; Durgapal P; Bal C; Kumar R
    Rev Esp Med Nucl Imagen Mol; 2015; 34(1):49-52. PubMed ID: 25065972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidental Detection of Second Primary in Bladder on PET scan of a Patient with Colon Adenocarcinoma.
    Rana MF; Mufty S; Hassan A
    J Pak Med Assoc; 2022 Nov; 72(11):2341-2343. PubMed ID: 37013322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detecting Metastatic Bladder Cancer Using (18)F-Fluorodeoxyglucose Positron-Emission Tomography/Computed Tomography.
    Öztürk H
    Cancer Res Treat; 2015 Oct; 47(4):834-43. PubMed ID: 25687863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Positron emission tomography/computed tomography with 18F-fluorocholine improve tumor staging and treatment allocation in patients with hepatocellular carcinoma.
    Chalaye J; Costentin CE; Luciani A; Amaddeo G; Ganne-Carrié N; Baranes L; Allaire M; Calderaro J; Azoulay D; Nahon P; Seror O; Mallat A; Soussan M; Duvoux C; Itti E; Nault JC
    J Hepatol; 2018 Aug; 69(2):336-344. PubMed ID: 29518452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison between the diagnostic accuracies of 18F-fluorodeoxyglucose positron emission tomography/computed tomography and conventional imaging in recurrent urothelial carcinomas: a retrospective, multicenter study.
    Zattoni F; Incerti E; Colicchia M; Castellucci P; Panareo S; Picchio M; Fallanca F; Briganti A; Moschini M; Gallina A; Karnes JR; Lowe V; Fanti S; Schiavina R; Rambaldi I; Ficarra V; Evangelista L
    Abdom Radiol (NY); 2018 Sep; 43(9):2391-2399. PubMed ID: 29302738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preoperative lymph-node staging of invasive urothelial bladder cancer with 18F-fluorodeoxyglucose positron emission tomography/computed axial tomography and magnetic resonance imaging: correlation with histopathology.
    Jensen TK; Holt P; Gerke O; Riehmann M; Svolgaard B; Marcussen N; Bouchelouche K
    Scand J Urol Nephrol; 2011 Mar; 45(2):122-8. PubMed ID: 21231796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 18F-FDG PET/CT of transitional cell carcinoma.
    Patil VV; Wang ZJ; Sollitto RA; Chuang KW; Konety BR; Hawkins RA; Coakley FV
    AJR Am J Roentgenol; 2009 Dec; 193(6):W497-504. PubMed ID: 19933624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 18F-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography in muscle-invasive bladder cancer.
    Einerhand SMH; van Gennep EJ; Mertens LS; Hendricksen K; Donswijk ML; van der Poel HG; van Rhijn BWG
    Curr Opin Urol; 2020 Sep; 30(5):654-664. PubMed ID: 32701719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chromophobe renal cell carcinoma mimicking cortical invasion by synchronous invasive urothelial carcinoma of the intra-renal collecting system on CT urography.
    Yu R; Gohla G; Haider EA
    Int Braz J Urol; 2016; 42(2):392-4. PubMed ID: 27256197
    [No Abstract]   [Full Text] [Related]  

  • 18. Positron emission tomography and positron emission tomography/computerized tomography of urological malignancies: an update review.
    Bouchelouche K; Oehr P
    J Urol; 2008 Jan; 179(1):34-45. PubMed ID: 17997425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The diagnostic accuracy of 18F-fluorodeoxyglucose positron emission tomography and computed tomography in staging bladder cancer: a single-institution study and a systematic review with meta-analysis.
    Soubra A; Hayward D; Dahm P; Goldfarb R; Froehlich J; Jha G; Konety BR
    World J Urol; 2016 Sep; 34(9):1229-37. PubMed ID: 26847182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chest radiography or chest CT plus head and neck CT versus
    Kim Y; Roh JL; Kim JS; Lee JH; Choi SH; Nam SY; Kim SY
    Oral Oncol; 2019 Jan; 88():109-114. PubMed ID: 30616780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.